Dr. Brian Ardis 072120

21 de jul. de 2020 · 10m 6s
Dr. Brian Ardis 072120
Descripción

Dr. Bryan Ardis says Remdesivir is Dangerous, and he can't believe that Remdesivir is the NIH demanded protocol in Hospitals in America. He examines this drug from top to bottom...

mostra más
Dr. Bryan Ardis says Remdesivir is Dangerous, and he can't believe that Remdesivir is the NIH demanded protocol in Hospitals in America. He examines this drug from top to bottom - What are the side effects? Where is the FDA Approval? Who benefits financially from its use?

Dr. Bryan Ardis - CEO of ArdisLabs.com

In early 2020 Dr. Ardis lost his Father-In-Law because of ill-advised hospital protocols. Since that time Dr Ardis has been on a mission to help educate the public about the dangers to Americans in many of our "institutes of health." He hopes to inform and inspire those who struggle with personal health issues, deliver real research, & applicable information that can help free Americans from emotional despair created by symptoms and disease. His podcast "The Dr Ardis Show" can be found on our Dr Ardis Show YouTube page and Vokal Media platform.

Dr. Ardis 2 practices helped thousands of patients from all over the world including from as far away as the Philippines, Taiwan, Australia, Barbados, Italy, Scotland & many more. He sold Ardis Healing Center in October of 2018, and now consults the 3 practitioners who have taken over the practice, which now carries the name North Texas Healing Center. Dr. Ardis co-founded and formulates products for TruLabs LLC.
mostra menos
Información
Autor NewsRadio 105-5 WERC
Página web -
Etiquetas

Parece que no tienes ningún episodio activo

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Actual

Portada del podcast

Parece que no tienes ningún episodio en cola

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Siguiente

Portada del episodio Portada del episodio

Cuánto silencio hay aquí...

¡Es hora de descubrir nuevos episodios!

Descubre
Tu librería
Busca